BioCatalyst

rF1V-1018, rF1V-1018, rF1V-1018, rF1V-1018 — catalyst calendar

1 verified catalyst event(s) referencing rF1V-1018, rF1V-1018, rF1V-1018, rF1V-1018, each linked to its official source. Verified as of 2026-10-01.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-29
in 4mo
ESTIMATED
 READOUT
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55
Phase 2 · Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis
 Dynavax Technologies Corporation rF1V-1018, rF1V-1018, rF1V-1018, rF1V-10 ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.